Clinical Trials

Through five years following initial implantation in an FDA-approved study, the Talent Abdominal Stent Graft from Medtronic, Inc., demonstrated durable safety and effectiveness in patients with abdominal aortic aneurysms.

Cook Medical has initiated enrollment in a U.S. clinical trial of its high-precision, next-generation Zenith® Low Profile AAA Endovascular Graft (Zenith AAA LP).

Spinal Restoration, Inc. announced today it has submitted the 6-month primary endpoint results from an ongoing 2-year IDE pilot study of the Biostat® System to the Food and Drug Administration.

St. Jude Medical, Inc. today announced the completion of patient implants in its U.S. pivotal clinical study of deep brain stimulation for the symptomatic treatment of Parkinson’s disease, a neurological disorder affecting approximately 6.3 million people worldwide.

This study examined the 20-year follow-up of the cemented Anatomical Graduated Component total knee replacement carried out between 1983 and 2004.

This study investigated a series of Kinemax knee replacements where the survival rate was only 75% at nine years, compared with previously recorded rates of 96% over ten years and tried to ascertain the reason for the significantly lower survival rate.

Three patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first in the United States to be implanted with a next-generation artificial heart pump called the DuraHeart™ Left-Ventricular Assist System.

Hip resurfacing can be a good alternative to total hip replacement in young adults because it conserves bone and it has acceptable short- to medium-term results. However, there have been concerns about fractures of the femoral neck with this procedure.

Researchers present the latest advances in a technology that continues to change the face of gastroenterology and surgery, known as Natural Orifice Translumenal Endoscopic Surgery®, or NOTES®, at Digestive Disease Week® 2009 (DDW®).

Enterostomal therapy nurses and people living with an ostomy reported very high levels of satisfaction with a new moldable skin barrier pioneered by ConvaTec Ostomy Care, according to results from a prospective evaluation published this month.

NewYork-Presbyterian Hospital and Columbia University Medical Center, together with the Cardiovascular Research Foundation, announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published in the May 7 New England Journal of Medicine.

Boston Scientific Corporation today welcomed publication of results from the ISAT clinical trial showing patients with a ruptured intracranial aneurysm treated with endovascular coil embolization are 23 percent less likely to die within five years compared to patients who undergo surgical clipping.

Medtronic, Inc. announced new data presented today on the safety and effectiveness of Medtronic’s CoreValve system via a novel, subclavian approach.

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich’s Genous™ Bio-engineered R stent™ Compared to Drug-Eluting Stents.

Edwards Lifesciences Corporation, the world leader in the science of heart valves, today announced at EuroPCR 2009 the results from its first post-market study of consecutively enrolled Edwards SAPIEN transcatheter aortic valve patients.

MEDRAD Interventional™/Possis® announced that it has reached key milestones in bringing the Paccocath® Technology closer to market.